Ohio · 2025-2026 Regular Session
To enact section 3902.65 of the Revised Code to cap cost sharing for prescription insulin drugs, diabetes devices, and diabetic ketoacidosis devices.
Referred to committee: Health (2025-05-14)
See how HB 263 affects you on CapitolKey
Browse more bills · CapitolKey home